Dr. Deepak L. Bhatt Profile Banner
Dr. Deepak L. Bhatt Profile
Dr. Deepak L. Bhatt

@DLBHATTMD

Followers
36,638
Following
846
Media
184
Statuses
15,885

Dr. Deepak L. Bhatt is Director of Mount Sinai Heart and the Dr. Valentin Fuster Professor of Cardiovascular Medicine. Bio and COI: .

New York City
Joined December 2009
Don't wanna be here? Send us removal request.
Explore trending content on Musk Viewer
Pinned Tweet
@DLBHATTMD
Dr. Deepak L. Bhatt
2 years
After 14 wonderful years at @BrighamWomens , @MassGenBrigham , @DanaFarber , and @VABostonHC , I am happy to announce that I will be the Director of @MountSinaiHeart at @MountSinaiNYC and the Dr. Valentin Fuster Professor of CV Medicine at @IcahnMountSinai .
263
84
1K
@DLBHATTMD
Dr. Deepak L. Bhatt
2 years
I’m happy to share that I’m starting a new position as Director of Mount Sinai Heart at Mount Sinai Health System!
83
22
864
@DLBHATTMD
Dr. Deepak L. Bhatt
2 years
Tweet media one
77
28
764
@DLBHATTMD
Dr. Deepak L. Bhatt
5 years
Proud to be named a Highly Cited Researcher 2019 for significant influence in Clinical Medicine through publication of multiple papers, highly cited by my peers, over the last decade. See the full list of #HighlyCitedResearchers 2019
74
33
526
@DLBHATTMD
Dr. Deepak L. Bhatt
2 years
Surprise 80th Birthday Party for Dr. Fuster at @MountSinaiHeart ! (and it was a surprise - I told him the hospital President @DrDavidReich called an emergency meeting and he had to attend) @IcahnMountSinai @MountSinaiNYC @SinaiCards @rowpower @SWBienMD @MSHCardsCT @DOMSinaiNYC
Tweet media one
20
26
505
@DLBHATTMD
Dr. Deepak L. Bhatt
6 years
A great day at ⁦ @BrighamWomens ⁩ celebrating Dr Braunwald and naming a building at BWH after him! So honored to speak at this incredible event!
Tweet media one
12
40
388
@DLBHATTMD
Dr. Deepak L. Bhatt
4 years
@adamfeuerstein Not sure what journalistic purpose your inflammatory tweet serves, other than, well, to be inflammatory. Physicians and scientists have every right to publish valid findings. My clearly stated disclosures don't change the facts in the paper. Reflect a bit about your own motives.
28
46
348
@DLBHATTMD
Dr. Deepak L. Bhatt
3 months
Congratulations to @Drroxmehran who will be the incoming vice president and then president of @ACCinTouch ! We celebrated this and all her many achievements today at @MountSinaiHeart . #cardiology #cardiotwitter #cardioX
Tweet media one
25
24
333
@DLBHATTMD
Dr. Deepak L. Bhatt
5 years
ACC 2020 live meeting now officially canceled (as I think everyone was expecting). Virtual meeting options to follow - very exciting! Perhaps this crisis will move us as a field towards more innovative, time- and cost-efficient ways of disseminating knowledge.
17
66
327
@DLBHATTMD
Dr. Deepak L. Bhatt
1 year
@zahifayad
zahifayad
1 year
@DLBHATTMD endowed chair ceremony. a great moment for @MountSinaiHeart
Tweet media one
6
0
30
33
12
274
@DLBHATTMD
Dr. Deepak L. Bhatt
2 years
Wonderful night at @crfheart Pulse gala celebrating another major award to @Drroxmehran ! @MountSinaiHeart @georgedangas @DrDavidReich
Tweet media one
17
18
249
@DLBHATTMD
Dr. Deepak L. Bhatt
2 months
At the ⁦ @ElsevierConnect ⁩ booth at ⁦ @escardio ⁩ with Dr Peter Libby and Dr Bob Bonow and the Braunwald’s Heart disease family of textbooks. #cardiology
Tweet media one
7
17
210
@DLBHATTMD
Dr. Deepak L. Bhatt
2 years
What an honor to be with the legendary ⁦ @MortonKern ⁩ at ⁦ @SCAI ⁩! He has taught me so much through the years.
Tweet media one
13
7
240
@DLBHATTMD
Dr. Deepak L. Bhatt
5 years
Cardiovascular risk in the USA: Now we can REDUCE-IT w/ icosapent ethyl, including a statistically significant 30% reduction in all-cause mortality in US patients! REDUCE-IT USA: Results from the 3,146 Patients Randomized in the United States | Circulation
4
69
204
@DLBHATTMD
Dr. Deepak L. Bhatt
2 years
Farewell reception last night at @BrighamWomens for Dr. Dave Faxon, prior @American_Heart president, prior @SCAI president, prior @CircIntv editor, prior @VABostonHC Chief of Cardiology. A great doctor, researcher, teacher, mentor, and friend. #cardiology #cardiotwitter
Tweet media one
11
9
207
@DLBHATTMD
Dr. Deepak L. Bhatt
4 years
See the presentation by Dr. @benpeterson71 for the striking results from REDUCE-IT REVASC! A 32% reduction in stenting and a 39% reduction in coronary artery bypass surgery - quite remarkable in a blinded, placebo-controlled trial with independent, blinded endpoint adjudication.
Tweet media one
10
55
200
@DLBHATTMD
Dr. Deepak L. Bhatt
6 years
Honored to be named a Highly Cited Researcher for 2018. See the full results at
19
12
191
@DLBHATTMD
Dr. Deepak L. Bhatt
6 years
Congratulations @MRMehraMD on being named the first recipient of the William Harvey Distinguished Chair in Advanced Cardiovascular Medicine at @BrighamWomens - and a nice touch to have Dr. Braunwald bless your Chair! I am so happy for you and Gayatri and your wonderful family!
Tweet media one
7
9
180
@DLBHATTMD
Dr. Deepak L. Bhatt
2 years
Holiday warmth at the #NYCVS 2022 faculty dinner hosted by Dr. Valentin Fuster. @MountSinaiHeart @MountSinaiNYC @IcahnMountSinai @NYSCACC @ACCinTouch @JACCJournals
Tweet media one
6
7
179
@DLBHATTMD
Dr. Deepak L. Bhatt
5 years
Dr. Deepak L Bhatt is currently the executive director of ...
25
7
178
@DLBHATTMD
Dr. Deepak L. Bhatt
4 years
2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult #cardiotwitter #cardiology #lipids #cholesterol #triglycerides
1
58
162
@DLBHATTMD
Dr. Deepak L. Bhatt
4 years
Dr Libby and Dr Benacerraf's Zoom New Year's Eve Party with Dr Braunwald, Dr Pfeffer, Dr Goldhaber, Dr Kirshenbaum, Dr Adler, @JfKeaney , @MRMehraMD , @DLBHATTMD and families - great way to end 2020! @BrighamWomens @BrighamResearch @BrighamFellows @harvardmed @MassGenBrigham
Tweet media one
8
6
159
@DLBHATTMD
Dr. Deepak L. Bhatt
4 years
Federal Judge Invalidates Icosapent Ethyl Patents – But Based on a Common Statistical Mistake @SSRN #cardiology #cardiotwitter
31
52
156
@DLBHATTMD
Dr. Deepak L. Bhatt
2 years
Very lucky to see this original letter by #Tolkien who was a Fellow at @PembrokeOxford at @UniofOxford . @OxfordSBS
Tweet media one
6
6
159
@DLBHATTMD
Dr. Deepak L. Bhatt
3 years
FDA approves empagliflozin for reducing risk of cardiovascular death, hospitalization among adult HFpEF patients #CardioTwitter #HeartFailure #Cardiology @JavedButler1
1
36
155
@DLBHATTMD
Dr. Deepak L. Bhatt
2 years
Standing next to C. S. Lewis' inspiration for Aslan at @UniofOxford ! @OxfordSBS @PembrokeOxford
Tweet media one
5
3
155
@DLBHATTMD
Dr. Deepak L. Bhatt
5 years
Great going away party for @EldrinL as he heads off from @BrighamWomens to @StanfordDeptMed - shown here with Dr. Paula Johnson (President of @Wellesley College), Dr. Braunwald, and me. @JfKeaney @HeartBobH @RonBlankstein @DLBHATTMD @MRMehraMD @BrighamFellows @StanfordCVI
Tweet media one
3
8
153
@DLBHATTMD
Dr. Deepak L. Bhatt
4 years
@ESC_Journals
European Society of Cardiology Journals
4 years
Effect of icosapent ethyl on progression of #coronary atherosclerosis in patients with elevated triglycerides on statin therapy: final results of the EVAPORATE trial #EHJ #ESCCongress #cardiotwitter
Tweet media one
Tweet media two
2
46
107
9
43
148
@DLBHATTMD
Dr. Deepak L. Bhatt
3 years
Major analysis from REDUCE-IT now published in @JACCJournals by the amazingly talented @PrakritiGaba - Prevention of Cardiovascular Events and Mortality With Icosapent Ethyl... #CardioTwitter @gabrielsteg @mmillermd1 @CBallantyneMD @CMichaelGibson
5
50
149
@DLBHATTMD
Dr. Deepak L. Bhatt
4 years
VASCEPA (Icosapent Ethyl) Receives Further Inclusions in Guidelines from International Medical Societies for its ... #cardiotwitter @mmillermd1 @CBallantyneMD @gabrielsteg @CMichaelGibson @EliotBrinton @jctardif_mhi @cpcannon
7
47
147
@DLBHATTMD
Dr. Deepak L. Bhatt
5 years
A late-stage study showed that Vascepa can reduce the risk of cardiovascular-disease events in patients with elevated triglyceride levels who are high risk and on cholesterol-lowering drugs via @WSJ
9
23
141
@DLBHATTMD
Dr. Deepak L. Bhatt
4 years
@adamfeuerstein My job is that I am literally in the hospital on call right now taking care of sick patients. So, no more time to waste receiving your vitriol. At least your Twitter bio was accurate, you do "attack viciously" - glad you are proud of it.
13
14
144
@DLBHATTMD
Dr. Deepak L. Bhatt
1 year
A wonderful end of course ceremony at the @SheldonianOxUni with Dean @soumitradutta at @OxfordSBS ! Happy to be here at the end of our Executive #MBA journey with Dr. Ebrahim Barkoudah. @PembrokeOxford @UniofOxford @oxfordalumni
Tweet media one
21
3
146
@DLBHATTMD
Dr. Deepak L. Bhatt
7 years
Sometimes an NSTEMI is just a STEMI without ST elevation - very high risk @DLBHATTMD @gabrielsteg @HarshGMD
@ESC_Journals
European Society of Cardiology Journals
7 years
25% patients presenting with #NSTEMI show an occluded #coronary #artery & these patients have worse prognosis
Tweet media one
Tweet media two
2
91
100
9
92
133
@DLBHATTMD
Dr. Deepak L. Bhatt
6 years
After @escardio course in Mumbai, dining with Professor Lars Ryden at Peshawri. Now that's a big naan!
Tweet media one
8
2
128
@DLBHATTMD
Dr. Deepak L. Bhatt
1 year
Tweet media one
1
8
123
@DLBHATTMD
Dr. Deepak L. Bhatt
2 years
Being presented at #AHA22 by Sam Sherratt, self-funded work from the lab of Dr. Preston Mason in collaboration with Dr. Peter Libby showing no effect of mineral oil (or corn oil for that matter) on LDL oxidation. It's the EPA. #cardiology #cardiotwitter
12
33
127
@DLBHATTMD
Dr. Deepak L. Bhatt
7 years
Safety and efficacy of dual vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of randomized clinical trials | European Heart Journal | Oxford Academic
4
69
125
@DLBHATTMD
Dr. Deepak L. Bhatt
4 years
SOLOIST in print in @NEJM - benefits of SGLT2 inhibition in acute #HeartFailure (after initial stabilization). Consistent results in patients with reduced ejection fraction and, for the first time, in preserved ejection fraction! @gabrielsteg @cpcannon
5
29
124
@DLBHATTMD
Dr. Deepak L. Bhatt
3 years
Fun night out at the @AmericanHeartMA Boston Heart and Stroke Ball where Dr. Peter Libby won the Paul Dudley White Award! Celebrating with the one and only Dr. Marc Pfeffer and my wife Shanthala. Event expertly hosted by @JessicaBrownTV . #cardiotwitter @BrighamWomens @AHAScience
Tweet media one
5
5
118
@DLBHATTMD
Dr. Deepak L. Bhatt
3 years
Great presentation by Dr. @wendywangmd at #ACC21 on the low HDL/high triglycerides subgroup from REDUCE-IT (large benefit; 30-40% risk reductions in prespecified subgroups, guideline and also STRENGTH cutoffs): #CardioTwitter @gabrielsteg @mmillermd1
4
34
115
@DLBHATTMD
Dr. Deepak L. Bhatt
6 years
Based on the ODYSSEY trial published in @NEJM the @US_FDA has approved alirocumab to prevent heart attack, stroke, and unstable angina requiring hospitalization. Congratulations @gabrielsteg - great development for patients and thanks for involving me in the trial. @DLBHATTMD
6
29
114
@DLBHATTMD
Dr. Deepak L. Bhatt
7 years
Just flew in from Boston to DC for @ACCinTouch Board of Trustees meeting. @JohnKerry on flight, so my wife told me to go talk to him. But then on escalator in front of us, girl's shoelace getting sucked into escalator, foot trapped, I broke the shoelace, saved the foot!
Tweet media one
8
4
115
@DLBHATTMD
Dr. Deepak L. Bhatt
11 months
@MountSinaiHeart ⁩ cardiology fellow outing to watch the ⁦ @BrooklynNets ⁩ thanks to Dr. Goldman courtesy of Mr. Rabin.
Tweet media one
3
1
113
@DLBHATTMD
Dr. Deepak L. Bhatt
5 years
I really enjoyed speaking with @CMichaelGibson about #COVID19 - he is not just an expert on the topic, but also a patient! Thanks for sharing your personal story of #COVID19 illness, self-quarantine, and recovery - many people will benefit.
@CMichaelGibson
C. Michael Gibson MD
5 years
@DLBHATTMD & I talk about #Coronavirus here
Tweet media one
Tweet media two
2
4
18
3
23
112
@DLBHATTMD
Dr. Deepak L. Bhatt
7 years
New Year's Eve party at Dr. Libby's - Dr. Braunwald telling me a joke!
Tweet media one
5
4
109
@DLBHATTMD
Dr. Deepak L. Bhatt
5 years
Thanks. I think this advance can now helps millions of American patients (and hopefully tens of millions more worldwide).
13
6
101
@DLBHATTMD
Dr. Deepak L. Bhatt
1 year
Thank you to the SOLOIST-WHF and SCORED executive and steering committees for believing in the science. Prior late-breakers at @AHAMeetings and published in @NEJM . #Cardiology #CardioTwitter #HeartFailure #Diabetes #KidneyDisease @gabrielsteg @cpcannon @MkosiborodMD @MarcoMetra
@CardiologyToday
Cardiology Today
1 year
Sotagliflozin approved for anyone with #heartfailure regardless of EF or diabetes status #CardioTwitter #Cardiology @DLBHATTMD
1
5
32
4
24
107
@DLBHATTMD
Dr. Deepak L. Bhatt
8 months
A once-in-a-lifetime event! The Legends Colloquium: A Conversation Between Eugene Braunwald and Valentin Fuster | Journal of the American College of Cardiology #CardioTwitter #Cardiology @MountSinaiHeart @BrighamWomens @MountSinaiNYC @IcahnMountSinai
4
23
106
@DLBHATTMD
Dr. Deepak L. Bhatt
4 years
To understand the truth about EPA and icosapent ethyl, make sure to see our comprehensive supplement available freely online at @ESC_Journals . Two independent randomized trials - REDUCE-IT (placebo) and JELIS (no placebo) - prove it works. #cardiotwitter
3
22
104
@DLBHATTMD
Dr. Deepak L. Bhatt
4 years
Alcohol consumption, even just a daily glass of wine, leads to a heightened risk of AFib #cardiotwitter
14
31
102
@DLBHATTMD
Dr. Deepak L. Bhatt
3 years
Big news for the field of #heartfailure - approval of empagliflozin for patients with HFrEF. @JavedButler1 #cardiotwitter #diabetes #cardiology
1
28
99
@DLBHATTMD
Dr. Deepak L. Bhatt
3 years
Cost-effectiveness analysis from REDUCE-IT now out. Bottom line, icosapent ethyl is extremely cost-effective in high-risk patients with hypertriglyceridemia despite statins. via @JAMANetworkOpen part of @JAMANetwork @gabrielsteg @mmillermd1 @CBallantyneMD
2
31
99
@DLBHATTMD
Dr. Deepak L. Bhatt
4 years
Effect of Icosapent Ethyl on Progression of Coronary Atherosclerosis in Patients with Elevated Triglycerides on Statin Therapy: A prospective, placebo-controlled randomized trial (EVAPORATE): Interim Results #cardiology #cardiotwitter
4
18
96
@DLBHATTMD
Dr. Deepak L. Bhatt
7 years
Just out on @TheLancet website - CABG the clear choice for patients with diabetes and multivessel disease @DLBHATTMD @GreggWStone
2
62
99
@DLBHATTMD
Dr. Deepak L. Bhatt
6 years
Fantastic video summary of the REDUCE-IT trial by @NEJM - they really know how to make data easy to digest! @DLBHATTMD @gabrielsteg @mmillermd1 @JWatch @NEJMres360
@NEJM
NEJM
6 years
New Quick Take video: Reducing Risk in Hypertriglyceridemia
Tweet media one
1
53
88
1
41
98
@DLBHATTMD
Dr. Deepak L. Bhatt
5 years
At ⁦ @AHAScience ⁩ behind the big stage with the one and only President ⁦ @HeartBobH ⁩ and I had to act quick to get a photo with him wearing a tie!
Tweet media one
6
6
95
@DLBHATTMD
Dr. Deepak L. Bhatt
2 years
Just published in @NEJM , a phase 2 trial of the aldosterone synthase inhibitor baxdrostat in resistant #hypertension that showed significant reductions in systolic and diastolic blood pressure with the highest dose tested:
2
26
94
@DLBHATTMD
Dr. Deepak L. Bhatt
2 years
See the latest data from REDUCE-IT - large reductions in MI, with a significant ~50% reduction in big MIs. #ESCCongress #esccongress2022 #cardiology #cardiotwitter #prevention @gabrielsteg @mmillermd1 @rgiugliano @CBallantyneMD @CMichaelGibson
@ACCinTouch
American College of Cardiology
2 years
Dr. Deepak Bhatt @DLBHATTMD presents updates to the REDUCE-IT trial at #ESCCongress . Read the latest updates here:
Tweet media one
0
10
37
1
37
95
@DLBHATTMD
Dr. Deepak L. Bhatt
2 years
Tweet media one
2
3
94
@DLBHATTMD
Dr. Deepak L. Bhatt
3 years
Go fish? Omega-3 fatty acids boost outcomes, reduce cardiovascular mortality
3
23
94
@DLBHATTMD
Dr. Deepak L. Bhatt
4 years
Now posted online at #AHA20 is a very insightful and timely poster from Dr. Preston Mason's lab - Eicosapentaenoic Acid, but Not Docosahexaenoic Acid or a Mixed Omega-3 Fatty Acid Supplement, Inhibits Low-density Lipoprotein Oxidation in a Time-dependent Manner - look for it!
6
18
96
@DLBHATTMD
Dr. Deepak L. Bhatt
3 years
Great job by @safinmc leading this comprehensive meta-analysis on omega-3 fatty acids on cardiovascular outcomes! (EPA looks good) #cardiotwitter #prevention @EClinicalMed @ErinMichos @webmd11 @CBallantyneMD @mmillermd1 @rblument1 @khurramn1 @ShahzebKhanMD
6
35
93
@DLBHATTMD
Dr. Deepak L. Bhatt
4 years
At #ESCCongress by @BudoffMd - Mechanistic insights into the large benefits in REDUCE-IT: Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy: final results of the EVAPORATE trial
5
23
92
@DLBHATTMD
Dr. Deepak L. Bhatt
4 years
Prominent Ohio cardiologist dies from COVID-19 #cardiotwitter
25
34
94
@DLBHATTMD
Dr. Deepak L. Bhatt
6 years
ACC late-breaking clinical trials announced
3
50
90
@DLBHATTMD
Dr. Deepak L. Bhatt
5 years
Viewpoint on DAPA-HF with Drs. Braunwald and Verma: The DAPA-HF Trial: A Momentous Victory in the War against Heart Failur...
2
28
91
@DLBHATTMD
Dr. Deepak L. Bhatt
5 years
Please see attached thoughts from Dr. Wang and myself on how we can learn from this tragedy of COVID-19 and make our healthcare system better. COVID-19: An Unintended Force for Medical Revolution?
3
41
90
@DLBHATTMD
Dr. Deepak L. Bhatt
5 years
National Lipid Association Scientific Statement on Icosapent Ethyl - American College of Cardiology
2
25
86
@DLBHATTMD
Dr. Deepak L. Bhatt
4 years
REDUCE-IT REVASC presented at @SCAI by @benpeterson71 now published in @CircAHA showing very large reductions in elective/urgent/emergent PCI/CABG with icosapent ethyl. #cardiotwitter #cardiology #prevention @mmillermd1 @CBallantyneMD @duanepinto @CMichaelGibson @BrighamFellows
@CircAHA
Circulation
4 years
Icosapent ethyl reduced first and total coronary revascularization in pts with elevated TGs and high cardiovascular risk, despite well-controlled LDL-C on a statin #AHAJournals @benpeterson71 @DLBHATTMD @BudoffMd @gabrielsteg
Tweet media one
0
36
83
3
22
88
@DLBHATTMD
Dr. Deepak L. Bhatt
4 years
Expert panel to provide update on lipid-lowering drugs #cardiology #cardiotwitter
2
11
88
@DLBHATTMD
Dr. Deepak L. Bhatt
4 years
Tune in to the encore late breaker for REDUCE-IT REVASC at the American Society of Preventive Cardiology 2020, with new data demonstrating the very early benefits seen with icosapent ethyl. via @MHExecutive
4
25
87
@DLBHATTMD
Dr. Deepak L. Bhatt
4 years
If you want a quick recap of icosapent ethyl through REDUCE-IT and beyond, here it is! Now in this @ESC_Journals supplement. Mechanisms of action, efficacy, and safety of icosapent ethyl: from bench to bedside #cardiotwitter #cardiology @escardio
6
24
89
@DLBHATTMD
Dr. Deepak L. Bhatt
4 years
Randomized Trials Versus Common Sense and Clinical Observation
1
33
89
@DLBHATTMD
Dr. Deepak L. Bhatt
7 years
Such an honor to share the stage with the amazing Dr. Braunwald at ESC!
Tweet media one
3
12
86